HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E.l.f. Beauty Taps The Brakes, But Still Nothing But Open Road Ahead

This article was originally published in The Rose Sheet

Executive Summary

With its mission "to make luxurious beauty accessible to all," e.l.f. is on track to post 17% growth in fiscal 2017. The Oakland, Calif.-based firm expects its gains to slow going forward, but leadership remains confident in the business model, which emphasizes speed to market with on-trend innovation at value prices.

You may also be interested in...



E.l.f. Cut Down To Size As US Distribution Gaps Shrink, Fans’ Eyes Wander

After recording boast-worthy sales increases of 20% and 18% in fiscal 2016 and 2017, respectively, e.l.f.’s growth is tapering off faster than anticipated. The company will counter with brand investments, better storytelling and sharper product mix in retailer doors, among other initiatives.

California’s Advancing Cosmetic Animal-Test Ban Poses Liabilities, Industry Says

Universities and other accredited labs often test cosmetic ingredients on animals to assess potential health risks without manufacturers’ involvement or even their knowledge. Under a proposed bill advancing in California, such studies could render companies that use those ingredients non-compliant and subject to fines.

L’Oréal Benefits From 'Skin-Care Comeback,' With Mass Makeup Slowing

The French beauty giant has reported back-to-back quarters of sluggish mass-market makeup growth, particularly in the US, but strong performances from luxury and skin-care products drove sales up 4%, reported, during the first half of fiscal 2017. L'Oreal is eager to reinvest proceeds from its sale of The Body Shop to increase profitability in the back half of the year, company leadership says.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel